Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Procuritas Capital Investors VI on its acquisition of Polarn O. Pyret AB
Mandate

Vinge advises Procuritas Capital Investors VI on its acquisition of Polarn O. Pyret AB

March 11, 2021 Employment and Benefits Banking and Finance Commercial Agreements Corporate Crime & Compliance Intellectual Property EU, Competition and Regulatory M&A IT, Telecommunications and Outsourcing

The clothing company Polarn O. Pyret AB is acquired by Procuritas Capital Investors IV from RNB Retail and Brands AB (publ) at a preliminary purchase price of SEK 330 million on a cash and debt-free basis.

Polarn O. Pyret is a Swedish brand for baby and childrenswear that started in 1976 with the goal of making clothes that let kids be kids. Polarn O. Pyret is a leading brand for high-quality kids wear in the Nordics, and their products are sold in several markets around the world.

The transaction is subject to approval by seller’s bondholders and the Swedish Competition Authority.

Vinge’s team consisted of Jonas Johansson together with, among others, Stina Bengtsson and Mikaela Falkner (M&A), Karolina Cohrs (Real estate), Linn Adelwald and Ludvig Wettergren (Banking and Finance), Sara Strandberg and Emil Lindwall (Employment), Christoffer Nordin (Commercial Agreements), Sofia Bergenstråhle (IP), Agnes Perbo (IT), Tove Lövgren Frisk (Compliance), Johan Wahlbom (Competition law) and VDR-specialist Viktoria Owetz Leyva.

 

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025